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Increased incidence world-wide of cancer and increased survival has also resulted in physicians seeing more
complications in patients with cancer. In many cases, complications are the first manifestations of the disease. They
may be insidious and develop over a period of months, or acute and manifest within minutes to days. Imaging
examinations play an essential role in evaluating cancer and its complications. Plain radiography and ultrasonography
(US) are generally performed initially in an urgent situation due to their wide availability, low cost, and minimal or no
radiation exposure. However, depending on a patient’s symptoms, evaluation with cross-sectional imaging methods
such as computed tomography (CT) and magnetic resonance imaging (MRI) is often necessary. In this review article,
we discuss some of the most important acute noninfectious oncological complications for which imaging methods
play an essential role in diagnosis.Introduction
Cancer has become one of the leading causes of natural
deaths worldwide. The high incidence of neoplasms in-
creased the medical care related to complications of this
disease in recent years. These complications may present
as an acute life-threatening or insidiously, taking weeks
or months to be recognized and treated. Moreover, it is
not uncommon such complications being the first mani-
festation of of the disease [1].
Cancer complications can be classified as the direct or
indirect effects of a tumor. Direct or structural effects
include invasion or mechanical compression of struc-
tures adjacent to the tumor. Indirect complications in-
clude systemic manifestations of the disease, such as
hypercoagulability, immune suppression, and paraneo-
plastic syndrome. Surgical complications and those asso-
ciated with the side effects of chemotherapy and/or
radiation therapy are also significant [1,2]. Table 1 lists
the more common acute oncological complications.* Correspondence: marcosduarte500@gmail.com
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article, unless otherwise stated.Imaging examinations play an essential role in evaluat-
ing cancer and its complications. Plain radiography and
ultrasonography (US) are generally performed initially in
an urgent situation due to their wide availability, low
cost, and minimal or no radiation exposure. However,
depending on a patient’s symptoms, evaluation with
cross-sectional imaging methods such as computed tom-
ography (CT) and magnetic resonance imaging (MRI) is
often necessary [3].
In this review article, we discuss some of the most im-
portant acute noninfectious oncological complications
for which imaging methods play an essential role in
diagnosis.Review
Spinal cord compression syndrome
Spinal cord compression occurs in 2.5–6% of patients
with cancer [4]. Early diagnosis of this oncological emer-
gency is extremely important to prevent neurological se-
quelae such as paralysis and loss of bowel/bladder
control, which may be permanent if diagnosis is delayed
by even a few hours. The prognosis is poorer in the
presence of paralysis or absence of a clinical response to
treatment [1,2,5].tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Table 1 Major noninfectious acute complications of cancer
patients per system
System Complications
Neurologic Cord compression syndrome
Intracranial hypertension/hydrocephalus
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drome occur in patients with previous cancer diagnoses
[6]. The most common and earliest symptom is back
pain, present in 90% of patients, which can precede
neurological symptoms by weeks [5]. Other symptoms
include radicular pain, motor weakness, sensory defi-
ciencies, gait disturbance, and urinary bladder or intes-
tinal dysfunction. The main prognostic factor is the
neurological state at the time of diagnosis; because long
term neurological deficits may not respond to treatment,
this diagnosis should always be suspected in patients
with cancer who develop pain in the dorsal area [6-9].
The thoracic vertebral column is most commonly af-
fected (70% of cases) [5]. The majority of cord compres-
sions are of extradural origin, secondary to metastatic
vertebral lesions that cause cortical erosion and impress
upon into the spinal canal. Cancers of the breast, lung,
and prostate are most frequently associated with thisFigure 1 A 61-year-old woman with breast cancer metastatic to the s
sagittal (B) post-contrast T1-weighted MR images of a patient with metasta
T6 (arrowhead), with high T2 signal intensity and intense contrast enhance
anterolaterally (arrow).condition, accounting for nearly two-thirds of all cases
[4]. Less frequently, tumors involving the paravertebral
area, such as lymphomas, sarcomas, and lung cancer,
can invade through intervertebral foramina and impress
upon the spinal cord. More common non-neoplastic
causes of cord compression that may be seen in the setting
of cancer include spinal fractures and abscesses [6-8].
MRI is the gold standard for the diagnosis of cord
compression [5,6]. This imaging modality enables defin-
ition of the extent of the compressed area and aids treat-
ment planning, such as radiation therapy. The use of
paramagnetic intravenous contrast improves the method’s
sensitivity, including in identifying leptomeningeal or
intramedullary metastases.
On MRI, malignant tumors in the spinal column gen-
erally present with low signal intensity on T1-weighted
images, high signal intensity on T2-weighted images,
and contrast enhancement. Such tumors impress upon
the spinal canal, dislocating and compressing the spinal
cord. This can result in high signal intensity of the cord
on T2-weighted images, which suggests edema (Figure 1).
When MRI is not available or is contraindicated, CT
with myelography is the method of choice [4]. When
this is not available, CT preferably with intravenous con-
trast may be performed. Bone scintigraphy and plain
films can show bone alterations, but do not visualize the
cord.
Intracranial hypertension
Increased intracranial pressure is a common and poten-
tially serious neurological complication in patients with
cancer [4,10-12]. It is caused mainly by intraparenchy-
mal metastatic disease. Among malignant tumors, lung
cancer, breast cancer, and melanoma most commonly
spread to the brain [4]. Other causes of increased intra-
cranial pressure include intratumor hemorrhage andpine leading to spinal cord compression syndrome. Axial (A) and
tic breast cancer showing a bone lesion in the posterior elements of
ment, impressing upon the spinal canal and dislocating the cord
Figure 2 A 37-year-old man with intracranial tumor with mass
effect. Axial post-intravenous contrast images. Computed tomographic
images of a patient with glioblastoma multiforme in the left frontal
lobe. The lesion with irregular contours and heterogeneous
enhancement (thin arrow) has mass effect characterized by
hypoattenuation (edema) of the adjacent white matter (arrowheads),
compression of the lateral ventricle, and contralateral deviation of the
medial line structures, with signs of subfalcine herniation (thick arrow).
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anoma, choriocarcinoma, and renal cell carcinoma are at
higher risk for bleeding. Hydrocephalus is most com-
monly obstructive or non-communicating, caused by le-
sions at the level of the foramen of Monro, the aqueduct
of Sylvius, or the fourth ventricle, but can also be non-
obstructive or communicating in patients with diffuse
leptomeningeal carcinomatosis, which obstructs the
arachnoid granulations, impeding cerebrospinal fluid re-
absorption [10-12].
Elevated intracranial pressure can result in general
symptoms, such as headache, nausea, vomiting, and re-
duced level of consciousness [11]. Headache is present
in about half of all patients with (primary or secondary)
cerebral tumors, especially those showing rapid or infra-
tentorial growth. Projectile vomiting without nausea is
frequently observed in patients with tumors of the pos-
terior fossa, which evolve into obstructive hydrocephalus
[11]. Other symptoms related to intracranial hyperten-
sion secondary to neoplastic disease are focal neuro-
logical dysfunction, cognitive deficits, and convulsions.
Elevated intracranial pressure and the effect of the mass
can cause ischemic encephalic vascular trauma and brain
herniation [10-12].
Although MRI is best for evaluating the central nervous
system, CT is generally the first examination performed in
urgent cases of intracranial hypertension [4]. On CT, one
can see mass effect (Figure 2), acute hemorrhage as in-
creased attenuation on non-contrast-enhanced CT, hydro-
cephalus and herniation [12]. MRI is more sensitive for
the identification of small metastases and leptomeningeal
implants, and can serve as a complementary imaging mo-
dality when CT shows no remarkable abnormality [1,4].
Superior vena cava syndrome
Superior vena cava syndrome results from partial or
complete obstruction of the blood flow in the superior
vena cava, causing reduction in venous return to the
head, neck, and upper limbs [1,2,13]. Although it is con-
sidered a classic oncological emergency, it is rarely im-
mediately life threatening [1].
Symptoms include cough, dyspnea, dysphagia, edema,
and congestion in the neck, face, and upper limbs. Col-
lateral venous circulation can cause distension of the
surface veins of the thoracic cavity wall [14-17].
More than 50% of patients with superior vena cava
syndrome become symptomatic after receiving a diagno-
sis of cancer due to severe clinical worsening of these
patients [1,17,18]. The prognosis for this syndrome de-
pends on that for the underlying disease. Malignant tu-
mors such as lung cancer, lymphomas, and metastatic
mediastinal tumors are responsible for more than 90%
of cases [15-17]. Venous thrombosis combined with the
presence of a catheter within the superior vena cava isan uncommon cause of this condition in patients with
cancer.
Although superior vena cava syndrome is diagnosed
clinically, CT is generally used to confirm it through
visualization of superior vena cava luminal narrowing in
association with the tumor mass (Figure 3) or thrombosis
[19]. CT can reveal the site of obstruction and enables the
differentiation of extrinsic compression caused by tumor
versus intravascular thrombosis. CT can also provide add-
itional information about the tumor, such as its size and
its relationship to other mediastinal structures [17,18].
CT should be performed with intravenous contrast
and images acquired in the later phases to guarantee op-
timal contrast of the brachiocephalic veins and to avoid
streak artifacts from arterial contrast [14,17]. If iodinated
contrast cannot be used MRI may also be performed. Se-
quences with and without contrast as well multiplanar
reconstruction aide MRI evaluation of tumor extent and
the compromise of the superior vena cava and adjacent
anatomical structures. Cross-sectional imaging is benefi-
cial for therapeutic planning, especially in patients with
conditions requiring a surgical approach [14-18].
Figure 3 A 55-year-old man with superior vena cava syndrome. Computed tomographic images of a patient with metastatic laryngeal
cancer showing an infiltrative mediastinal mass causing compression of the right pulmonary artery (thick arrow) and superior vena cava (thin
arrow). (A) Post-contrast axial slice. (B) Post-contrast coronal reconstruction.
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Malignant pericardial effusions are present in 10–15% of
patients with cancer and are caused by the obstruction
of lymphatic drainage, direct extension or hematogenous
metastasis [18,19]. Pericardial effusion is generally a late
finding in patients with metastatic cancer. The most
common causes are lung and breast cancers, followed by
melanoma, leukemia, and lymphoma [1,2,19]. Benign in-
flammatory pericardial thickening and effusion may arise
as side effects of radiation therapy and certain chemo-
therapies or from infectious causes in immunocom-
promised patients. Two-thirds of patients with this
condition are asymptomatic. The most common symp-
toms are dyspnea, orthopnea, fatigue, palpitations, and
dizziness [19].
Cardiac tamponade occurs when a quantity of liquid
that has accumulated in the pericardial sac causes re-
striction in diastolic expansion and hemodynamic in-
stability [20]. This is more common with rapid fluid
accumulations rather than slow accumulation. The main
signs on physical examination are paradoxical pulse,
tachycardia, hypotension, distension of the cervical veins,
weak peripheral pulse, and muffled heart sounds [20].
Echocardiography is the main modality used to con-
firm a diagnosis of pericardial effusion, to evaluate its
hemodynamic impact, and to guide pericardiocentesis
[21]. Cytological examination of the pericardial fluid
should be performed to confirm or exclude the presence
of neoplastic cells.
In some cases, radiography and thoracic CT per-
formed for other clinical reasons show signs of pericar-
dial effusion [19-21]. Chest x-rays may show an
increased transverse diameter of the cardiac area. CT
may show pericardial thickening with fluid attenuation
in most cases (Figure 4), but greater density may be
due to the presence of debris or hemorrhage. Evidenceof irregular thickening or tumor nodules in the peri-
cardium is rare. CT can also reveal signs of direct car-
diac insufficiency, such as hepatic congestion seen as
patchy attenuation of the liver and reflux of the con-
trast medium into the inferior vena cava and hepatic
veins [9,18,19].
Pleural effusion
Benign and malignant pleural effusions are common in
patients with cancer. These can lead to compression of
the adjacent pulmonary parenchyma and when large, dif-
ficulty breathing. Patients are commonly asymptomatic,
but may present with dyspnea, cough, thoracic pain,
weight loss, anorexia, and/or fatigue [22].
Benign pleural effusions may be secondary to compro-
mised lymph drainage, to infectious/inflammatory pro-
cesses, or to reduced oncotic pressure. Malignant pleural
effusions are typically caused by pleural compromise
from the underlying disease. Malignancies that most fre-
quently affect the pleura are lung, breast, and ovarian
cancers and lymphoma. Primary pleural tumors, such as
mesothelioma are quite rare and generally cause effusion
associated with the pleural mass [23,24].
Suspected pleural effusion can be confirmed by radi-
ography or ultrasound; the latter modality is also useful
in guiding thoracocentesis [24,25]. CT is important for
the evaluation of pulmonary parenchyma, exclusion of
other causes of dyspnea, and assessment of signs of
malignancy. Although most malignant pleural effusions
have a simple appearance on CT, with fluid attenuation
and without pleural thickening, the presence of circum-
ferential or nodular pleural thickening suggests malig-
nancy (Figure 5) [26]. Positron emission tomography/
CT can be useful in identifying the most suspicious
areas of pleural thickening to guide percutaneous nee-
dle biopsy [22-25].
Figure 4 A 72-year-old man with history of lung cancer presenting pericardial effusion/cardiac tamponade. (A) Echocardiogram
demonstrating hypoechoic pericardiac fluid (arrow) and through transmission. (B) Axial computed tomographic slice of the thorax obtained in a
mediastinal window after intravenous contrast administration showing a large pericardial effusion (thick arrow) and small bilateral pleural
effusions (thin arrows).
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Deep vein thrombosis and pulmonary thromboembolism
(PTE) are common complications in patients with can-
cer because of their hypercoagulable state, local tumor
effects, or treatment side effects [27]. Malignant tumors
most frequently associated with the development of PTE
are lung, colon, and prostate cancers [28]. The incidence
of venous thromboembolism is higher in patients receiv-
ing chemotherapy, reaching 10% in patients with ovarian
cancer or lymphoma and 28% in patients with malignant
gliomas [29]. Patients with cancer and PTE also have a
poorer prognosis, with mortality rate four to eight times
that of the general population with PTE [27-30].
It is found incidentally on imaging examinations per-
formed for other reasons in about 4% of patients with
cancer [31] and mainly affects small pulmonary arteries.
This finding should be reported urgently and treatment
initiated because it is associated with the presence ofFigure 5 A 36-year-old woman with breast cancer presenting severe
radiograph of the thorax showing opacification of the left hemithorax and
computed tomographic image of the thorax obtained in the mediastinal w
arrow), pleural thickening (arrowhead), and collapse of the left lower lobe (deep vein thrombosis and the development of new
thromboembolic events.
PTE is commonly asymptomatic or associated with
non-specific symptoms. Acute onset dyspnea is the most
suggestive symptom of PTE, followed by pleuritic pain.
Massive PTE can cause pulmonary hypertension and
signs of direct cardiac insufficiency. Chemotherapy, his-
tory of recent surgery, prolonged immobilization, or
signs of deep vein thrombosis are associated with devel-
oping PTE [27-29].
The differential diagnosis of PTE includes pulmonary
tumor thrombotic microangiopathy (PTTM), an ex-
tremely rare and serious complication in patients with
cancer caused by the presence of microemboli; it is asso-
ciated with adenocarcinomas, mainly of gastric origin
[32]. A patient with PTTM develops rapidly progressing
signs and symptoms of pulmonary hypertension and car-
diac failure, evolving to death in a few days [33,34].pleural effusion in the left hemithorax. (A) Anteroposterior
slight contralateral deviation of the mediastinal structures. (B) Axial
indow without contrast showing a large left pleural effusion (thin
thick arrow).
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many cases is performed post-mortem.
CT angiography is the method of choice to diagnose
and evaluate the extent of PTE. CT should be performed
using a specific angiographic protocol to achieve ad-
equate contrast of the pulmonary arteries, with suitable
venous access. Multiplanar reconstructions can be useful
in identifying the thrombus [32-35].
Acute PTEs are identified as one or more filling de-
fects in a pulmonary arterial branch (Figure 6). Some
cases include signs of pulmonary infarction, character-
ized by a wedge-shaped peripheral pulmonary parenchy-
mal opacity with a pleural base and an apex oriented
toward the occluded pulmonary artery. CT also provides
the opportunity to diagnose alternative conditions, such
as pneumonias or other pulmonary parenchymal dis-
eases, or pericardial, pleural, or mediastinal disease that
can contribute to dyspnea or thoracic pain.
In patients who cannot undergo CT angiography, the
method of choice is ventilation/perfusion pulmonary
scintigraphy. However, this modality may be unavailable
in urgent situations in many institutions. Another option
is MRI of the thorax, which enables the identification ofFigure 6 A 32-year-old woman with lymphoma presenting severe acu
pulmonary arteries demonstrating pulmonary emboli. (A) CT, coronal maxi
defects at the bifurcation and upper and lower segments of the right pulm
defects at the bifurcation of the right and left pulmonary arteries (white arr
the inferior lobar branch of the left pulmonary artery (white arrow). (D) MR
filling defects in the right pulmonary artery (white arrow).large thrombi with a balanced steady state free preces-
sion sequence, without the use of paramagnetic con-
trast (Figure 6) [36]. Thoracic x-rays may be normal or
yield nonspecific findings, such as focal opacities and a
small pleural effusion. Nonspecific and uncommon
x-ray signs have been described in patients with PTE,
including Hampton’s hump (peripheral triangular opa-
city with a pleural base), the Fleischner sign (enlarge-
ment of the pulmonary artery on the side of the PTE),
and the Westermark sign (pulmonary oligemia distal to
the PTE) [18].
PTTM shows nonspecific signs of pulmonary hyper-
tension on thoracic CT images. Because of changes to
the small vessels, typical findings of infectious bronchio-
litis, such as diffuse centrilobular opacities and a tree-in-
bud pattern, have also been described [32-35].
Intestinal obstruction
Intestinal obstructions are relatively common in patients
with cancer and can be caused by benign etiologies or
directly associated with the tumor [37,38]. Benign causes
include postoperative adhesions, actinic sequelae, and
inflammatory and infectious changes. Malignant causeste pulmonary thromboembolism. CT and MR images of the
mum intensity projection (MIP) reconstruction demonstrating filling
onary artery (white arrows). (B) CT, Axial slice demonstrating filling
ows). (C) CT, sagittal reconstructions demonstrating filling defects in
I with balanced steady state free precession sequence demonstrating
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and metastasis [38]. The clinical manifestations of be-
nign and malignant obstructions are very similar, and
imaging findings may be inconclusive. However, differ-
ential diagnosis has important implications for prognosis
and treatment [39,40].
Malignant causes of small intestinal obstruction are
less frequent than adhesions and inflammatory changes.
Malignant obstruction of the small intestine is caused
more frequently by metastatic tumors than by primary
tumors of the small intestine, which are responsible for
<2% of all gastrointestinal neoplasias [40]. Malignant ob-
struction of the colon is generally caused by primary
colorectal carcinoma [41,42].
Focal intestinal lesions can also cause intussusception
[43,44]. This condition is generally rare in adults, re-
sponsible for only 5% of intestinal obstructions [44,45].
In addition to foreign bodies, primary neoplasias of the
small intestine and colon and metastatic lesions (e.g.,
melanoma) can cause intussusception. When a neoplasia
is suspected, care should be taken to differentiate a real
tumor mass from a pseudomass caused by intussuscep-
tion [43-46].
Radiography can show signs of intestinal obstruction,
with gaseous distension of the small bowel or bowelFigure 7 A 29-year-old man Intestinal obstruction caused by intussus
picture of intestinal obstruction. Computed tomographic images obtained
with distention of the upstream small bowel loops. (A) Axial and (B) sagitt
invagination of the mesenteric adipose tissue toward its interior (arrows). (C
intussusception with parietal thickening of the invaginated small intestinal
surgical resection.loops forming air-fluid levels on upright images [44].
Small bowel follow-through is not done very commonly
presently. CT is generally performed to evaluate the site
and possible cause of obstruction and treatment planning.
CT findings that suggest malignant intestinal obstruction
are the presence of irregular parietal thickening or a mass
with soft-tissue density at the point of transition [42-44].
More commonly, no mass is found and the obstruction is
due to adhesions.
In intussusception, CT may shows pathognomonic
changes, such as the target sign or a “loop within loop”
pattern, with or without invaginated fat and mesenteric
vessels (Figure 7).
Inflammatory intestinal changes
Acute intestinal inflammatory changes are common in
patients with cancer, and various etiologies may be in-
volved in these processes [46-48]. Neutropenic colitis or
typhlitis is a cancer emergency that demonstrates trans-
mural inflammation of the cecum, proximal colon, and
terminal ileum [49]. It can develop in immunocom-
promised children and adults, for example those under-
going treatment for leukemia, receiving chemotherapy,
or that have undergone bone marrow transplant. Early
identification of this condition is fundamental because itception. Patient with metastatic melanoma evolving into a clinical
after oral and intravenous iodinated contrast show intussusception
al images showing the proximal portion of intussusception and
) Axial and (D) sagittal images showing the distal portion of
loops (arrows), which was confirmed as a melanoma metastasis after
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ity and mortality rates. Patients normally present with
fever, neutropenia, and abdominal pain [50].
Pseudomembranous colitis is caused by Clostridium
difficile infection, commonly after antibiotic treatment, it
should be considered especially in immunocompromised
cancer patients with abdominal complaints [51,52]. It is
the most common cause of diarrhea in hospitalized pa-
tients. Immunosuppressed patients undergoing chemo-
therapy who use broad-spectrum antibiotics are at risk
of developing this complication. Diarrhea, abdominal
pain, and fever typically manifest 1 week after the initi-
ation of antibiotic therapy. In some cases, this condition
can evolve into diffuse colitis and toxic megacolon [53].
Malignant tumors can also be associated with mesen-
teric ischemia and ischemic colitis [53]. Ischemia can be
secondary to vascular occlusion caused by tumor com-
pression/invasion or bacterial proliferation associated
with intestinal distension and chronic stasis [53].
The small intestine and colon are sensitive to radiation
therapy. Thus, actinic enteritis and colitis should be con-
sidered in the differential diagnosis when signs of an in-
flammatory process are present in previously irradiated
areas [54].
Ultrasound is useful in some cases, but CT is generally
the best method for the evaluation of intestinal com-
plaints [37,40,46]. CT is also useful for excluding other
causes of abdominal pain, including obstructions and in-
flammatory changes not associated with cancer, such asFigure 8 A 16-year-old boy with neutropenic typhlitis. Patient under tr
fossa. (A) Ultrasound image showing diffuse thickening of the walls of the
computed tomographic slices obtained after intravenous contrast administ
cecum wall and proximal portion of the ascending colon (arrows), compatappendicitis, diverticulitis, and inflammatory bowel dis-
eases [39,40,50].
CT may show nonspecific inflammatory findings, in-
cluding thickening and of the small intestine or colon,
with or without effacement and striations of pericolic
adipose tissue. The identification of pneumatosis, pneu-
moperitoneum, and pericolic collections often suggest
developing necrosis or perforation requiring urgent sur-
gical evaluation [40,50]. The presence of these findings
in the cecum, the proximal portion of the ascending
colon, and/or the distal ileum in an immunocomprom-
ised patient suggests a diagnosis of typhlitis (Figure 8)
[49]. Pseudomembranous colitis is characterized by dif-
fuse wall thickening generally along the entire colon, de-
scribed as an “accordion sign” [51,52].Biliary obstruction
Biliary obstruction can be secondary to biliary stasis in
patients with diffuse metastatic infiltration of the liver,
causing obstruction of the small intrahepatic bile ducts,
or it can occur due to compression of the main bile
ducts in patients due to more commonly metastatic dis-
ease or lymphoma or disease within the ducts, for ex-
ample, from cholangiocarcinoma [55].
Malignant tumors of the head of the pancreas and the
ampulla of Vater are common causes of obstruction of
the main bile ducts. Benign differential considerations
include pseudocyst from pancreatitits [56].eatment for leukemia, presented with abdominal pain in the right iliac
cecum and ascending colon (arrows). (B) Axial and (C) coronal
ration confirmed the ultrasound findings, showing thickening of the
ible with typhlitis.
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dark urine and pale-colored stools. In a patient with ab-
dominal pain and/or fever, the possibility of cholangitis
associated with biliary obstruction should also be con-
sidered [55,56].
Imaging methods should be able to define the pres-
ence or absence, level, and cause of bile duct obstruc-
tion. Ultrasound is generally the first method used and
has good diagnostic accuracy in detecting dilation of the
intra- and extrahepatic bile ducts [57]. A literature re-
view showed that ultrasound has a sensitivity of 71% in
delineating the level of obstruction and 51% in defining
the etiology. Fat and gastrointestinal gas may limit evalu-
ation [55].
Other methods for evaluating the bile ducts include
endoscopic retrograde cholangiopancreatography (ERCP),
which also allows biopsy. However, this is invasive, more
complex and commonly less readily available than CT or
MRI. Commonly, the second line test due to ease of avail-
ability is CT. MR also visualizes visceral structures, and
one can employ heavily T2-weighted MR sequences for
visualizing the ducts (MRCP) [56].
In cases of diffuse metastatic infiltration of the liver,
CT or MRI shows multiple hepatic lesions that are more
commonly infiltrative or confluent depending on the pri-
mary tumor, together with focal dilatation of the small
intrahepatic bile ducts adjacent to vessels of the hepatic
triad [55].
In cases of main bile duct compression, diffuse dilation
of the intra- and extrahepatic bile ducts is present up-
stream of the obstruction site (Figure 9). Such tumors
are commonly in the porta-hepatis, pancreas or at the
ampula. With pancreatic or ampullary tumors, one often
sees a “double duct sign” with dilatation of both the biliary
system and pancreatic duct. However, a normal-caliber
main pancreatic duct does not exclude the diagnosis. Cho-
langiocarcinomas can have different presentations rangingFigure 9 A 58-year-old man with biliary obstruction caused by adeno
abdomen obtained after intravenous contrast administration demonstrating
arrow), a pancreatic head mass (adenocarcinoma) with irregular contours and
duct (arrowheads).from an intraluminal polypoid lesion of a bile duct, wall
thickening or an infiltrative mass commonly with ill-
defined borders [55,56,58].
Urinary tract obstruction
Urinary tract obstruction can occur in patients with
retroperitoneal or pelvic tumors; these are more com-
monly gynecological or urological cancers of the cervix,
ovaries, bladder, and prostate [1,57]. Metastatic disease,
for example, from gastric cancer can also be seen. Sar-
coma or lymphoma as a cause is relatively rare. Unilat-
eral urinary obstruction does not normally cause acute
renal dysfunction because of compensation by the
contralateral kidney. Urinary obstruction can be seen
post surgery due to fibrosis involving the ureters. Obstruc-
tion of the urinary tract should be suspected in patients
with complaints of pain in the flank and sudden anuria
who have increased serum creatinine levels [57,59].
Ultrasound is the easiest way to detect the presence of
hydronephrosis [57,59]. However, CT can be superior for
determining the precise location of the obstruction, par-
ticularly when a pelvic or retroperitoneal mass is present.
Unilateral obstruction is usually characterized by focal le-
sions in the urinary tract with soft-tissue density and up-
stream urethral dilation (Figure 10) [57,59]. In bilateral
obstruction, the most common imaging findings are a
large heterogeneous mass involving both ureters and caus-
ing bilateral ureterohydronephrosis. Intravenous iodinated
contrast should be used with caution because patients can
already have a degree of renal dysfunction, which may be
exacerbated upon exposure to intravenous contrast. MR
urography is an effective alternative; it enables identifica-
tion of the site and cause of the obstruction in the major-
ity of cases [60]. A heavily T2-weighted sequence may be
used, but single shot T2 - fast spin echo (FSE) and bal-
anced steady state free precession sequences can also
serve to identify hydronephrosis and a mass [60].carcinoma of the pancreas. Axial (A) and (B) CT images of the
dilatation of the intra- (thin arrows) and extrahepatic bile ducts (thick
poorly defined borders (long arrow), and dilatation of the pancreatic
Figure 10 A 23-year-old man with urinary obstruction. (A) Axial and (B) coronal CT images of the abdomen obtained after intravenous
contrast administration showing mild hydronephrosis (arrowhead) on the left, with a discrete delay in the concentration of intravenous contrast
by the left kidney caused by a soft-tissue density mass (lymphoma) involving the middle third of the left ureter (arrow).
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Cancer patients can develop bleeding complications sec-
ondary to thrombocytopenia, tumor rupture, or hemor-
rhage from a vascular neoplasm.
Massive hemoptysis is generally used to describe the
expectoration of a large amount of blood and/or a rapid
rate of bleeding, and when it occurs secondary to malig-
nant disease, the mortality rate may be as high as 60%.
Bronchogenic carcinoma is the most common cause of
massive hemoptysis in patients older than 40 years.
Endobronchial metastases from carcinoid tumors, breast,
colon or kidney cancer, melanoma and sarcomas may
also cause hempoptysis. Hemoptysis in cancer patients
may also be caused by nonmalignant conditions, such as
fungal infections, or may be related to thrombocytopenia
or other coagulation disorders [1,61].Figure 11 A 24-year-old man on chemotherapy for non-Hodgkin
lymphoma presenting with thrombocytopenia and hemoptysis.
Axial unenhanced CT image of the thorax showing diffuse bilateral
ground-glass opacities, compatible with alveolar hemorrhage.In patients with cancer-related massive hemoptysis,
chest radiography may demonstrate abnormalities such as
tumors, cavitary lesions, pulmonary infiltrates (Figure 11),
and mediastinal masses. In stable patients, multidetector
CT of the chest can be performed before bronchoscopy to
help identify the site, cause, and vascular source of bleed-
ing. Multidetector CT angiography play a crucial role in
assessing the origin and course of the abnormal bronchial
arteries and nonbronchial systemic collateral vessels re-
sponsible for hemoptysis, directing the interventional
radiologist prior to catheter angiography [61,62].Figure 12 A 48-year-old man with hepatocellular carcinoma.
Axial unenhanced CT image of the abdomen showing a hepatic
mass on the right lobe with hyperattenuating components suggesting
acute bleeding.
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http://www.cancerimagingjournal.com/content/14/1/18Severe abdominal bleeding in cancer patients is a rare,
but potentially fatal complication that requires prompt
diagnosis and treatment. Malignant hemorrhage can
occur in an organ parenchyma or subcapsular space due
to direct tumor rupture or in the peritoneal cavity from
carcinomatosis or extension of visceral tumor rupture.
Hypervascular tumors, such as hepatocellular carcin-
oma, renal cell carcinoma, and melanoma, are the most
commonly associated to spontaneous hemoperitoneum.
Large size of the mass, a peripheral or subcapsular loca-
tion and increased vascularity are the most important
risk factors for intratumoral hemorrhage and subsequent
spontaneous rupture. In addition, patients with hemato-
logic malignancies can develop spontaneous hepatic or
splenic rupture [40,61].
Intratumoral hemorraghe is suggested by hyperecho-
genicity at US or hyperattenuating components at un-
enhanced CT (Figure 12). Hematomas are relatively
hyperdense to the unenhanced liver parenchyma during
the acute phase (typically 45–70 HU), but the attenuation
gradually decreases with time and may be lower in pa-
tients with decreased serum hematocrit level. At MRI, foci
of high T1 signal intensity are seen in acute hemorrhage,
however, the signal intensity of blood is also variable and
dependent on the age of hemorrhage [40,61,63].
At unenhanced CT, hemoperitoneum manifests as
high attenuation ascites (typically 30–45 HU). Subcapsu-
lar hematomas are elliptical high-attenuation collections
bound by the organ capsule in which they originate.
Thus, on CT images, the highest-attenuation hematoma,
or sentinel clot, is that closest to the site of bleeding.
Foci of active extravasation of intravenous contrast ma-
terial extending into or around the hematoma indicate
ongoing bleeding. Angiography of the visceral arteries
not only helps identify the source of bleeding but also
assists in treatment [40,61,63].Conclusion
Nowadays, the number of oncological visits is increasing
in clinical practice, especially those related to acute and
insidious noninfectious oncologic complications. Im-
aging methods play an essential role in diagnosis and as
soon as the support team recognizes these conditions,
the most appropriate therapeutic approach may be pro-
vided improving the quality of life and survival of these
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